David P. King is the former executive chairman and  CEO of Labcorp (NYSE: LH). He retired Oct. 31, 2019 as president and CEO after nearly two decades at the company, including almost 13 years as CEO, and stepped down on May 13, 2020 as executive chairman of the board. King is a respected senior healthcare leader who operates with a strong emphasis on deeply understanding the healthcare industry, strategic planning, “playing the long game,” and staying ahead of rapidly evolving industry trends and challenges.

Experience

Under King’s leadership, Labcorp transformed from a pure-play U.S. testing laboratory into a leading global life sciences company — tripling in size through a combination of organic growth and strategic acquisitions, entering  the Fortune 500 and being named to Fortune’s List of World’s Most Admired Companies. It recorded 2019 revenue of more than $11.5 billion, does business in more than 100 countries, and has over 65,000 employees worldwide. 

King is the board chair of Privia Health (PRVA) and ZimVie (ZIMV), as well as a number of private companies. He is a board member of Novant Health, a super-regional health system headquartered in Winston-Salem and Charlotte, NC. He is a member of the advisory board for Duke University’s Robert J. Margolis, MD, Institute for
Health Policy.

Education

King holds a bachelor’s degree, cum laude, from Princeton University and a Juris Doctor, cum laude, from theUniversity of Pennsylvania Law School.